Jonathan Shortt
Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schistosoma japonicum | 2 | 2021 | 31 | 1.270 |
Why?
| Schistosomiasis japonica | 2 | 2021 | 32 | 0.850 |
Why?
| Genetic Variation | 3 | 2021 | 870 | 0.730 |
Why?
| Metagenomics | 1 | 2021 | 131 | 0.690 |
Why?
| Microsatellite Repeats | 2 | 2018 | 136 | 0.690 |
Why?
| Selection, Genetic | 2 | 2021 | 242 | 0.680 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 439 | 0.450 |
Why?
| Pre-Eclampsia | 2 | 2023 | 165 | 0.380 |
Why?
| Receptors, KIR | 3 | 2022 | 92 | 0.380 |
Why?
| China | 3 | 2021 | 161 | 0.360 |
Why?
| Placenta | 2 | 2023 | 625 | 0.290 |
Why?
| Precision Medicine | 3 | 2024 | 337 | 0.260 |
Why?
| Thyroid Nodule | 1 | 2024 | 39 | 0.220 |
Why?
| Receptors, KIR3DS1 | 1 | 2022 | 6 | 0.200 |
Why?
| Receptors, KIR3DL1 | 1 | 2022 | 16 | 0.200 |
Why?
| Collagen Type VII | 1 | 2021 | 13 | 0.190 |
Why?
| Jews | 1 | 2021 | 18 | 0.190 |
Why?
| Epidermolysis Bullosa Dystrophica | 1 | 2021 | 21 | 0.190 |
Why?
| Genes, MHC Class I | 1 | 2021 | 32 | 0.190 |
Why?
| Killer Cells, Natural | 2 | 2021 | 380 | 0.180 |
Why?
| Desogestrel | 1 | 2021 | 40 | 0.180 |
Why?
| Lipopolysaccharide Receptors | 1 | 2021 | 81 | 0.180 |
Why?
| Thyroid Neoplasms | 1 | 2024 | 264 | 0.180 |
Why?
| Evolution, Molecular | 2 | 2021 | 430 | 0.170 |
Why?
| Pharmacogenetics | 1 | 2021 | 149 | 0.170 |
Why?
| Genotype | 2 | 2022 | 1760 | 0.160 |
Why?
| Snakes | 1 | 2018 | 20 | 0.160 |
Why?
| Lizards | 1 | 2018 | 34 | 0.150 |
Why?
| Heterozygote | 1 | 2019 | 251 | 0.150 |
Why?
| Biological Specimen Banks | 3 | 2024 | 94 | 0.150 |
Why?
| Primates | 1 | 2019 | 111 | 0.150 |
Why?
| Patient Acceptance of Health Care | 1 | 2023 | 681 | 0.140 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2021 | 1879 | 0.140 |
Why?
| Genotyping Techniques | 1 | 2017 | 69 | 0.140 |
Why?
| Delivery of Health Care | 1 | 2023 | 833 | 0.130 |
Why?
| Genetics, Population | 1 | 2017 | 188 | 0.130 |
Why?
| Phylogeny | 1 | 2018 | 789 | 0.120 |
Why?
| Genome | 1 | 2017 | 271 | 0.120 |
Why?
| Sequence Analysis, DNA | 1 | 2017 | 723 | 0.110 |
Why?
| Humans | 15 | 2024 | 114654 | 0.110 |
Why?
| Genomics | 3 | 2024 | 635 | 0.110 |
Why?
| Pilot Projects | 1 | 2017 | 1373 | 0.100 |
Why?
| HLA-B Antigens | 2 | 2022 | 56 | 0.100 |
Why?
| Animals | 4 | 2021 | 31698 | 0.090 |
Why?
| Phenotype | 3 | 2023 | 2796 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2021 | 1727 | 0.080 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2023 | 2094 | 0.080 |
Why?
| Colorado | 3 | 2024 | 4099 | 0.080 |
Why?
| Female | 7 | 2023 | 59488 | 0.070 |
Why?
| Signal Transduction | 1 | 2019 | 4512 | 0.070 |
Why?
| Iran | 1 | 2023 | 36 | 0.050 |
Why?
| Los Angeles | 1 | 2023 | 56 | 0.050 |
Why?
| Ion Channels | 1 | 2023 | 123 | 0.050 |
Why?
| Cesarean Section | 1 | 2023 | 169 | 0.050 |
Why?
| Pregnancy | 2 | 2023 | 5517 | 0.050 |
Why?
| Male | 4 | 2023 | 55579 | 0.050 |
Why?
| Chile | 1 | 2021 | 16 | 0.050 |
Why?
| Colombia | 1 | 2021 | 34 | 0.050 |
Why?
| Cross-Sectional Studies | 2 | 2022 | 4407 | 0.050 |
Why?
| Mississippi | 1 | 2021 | 20 | 0.050 |
Why?
| Genes, Recessive | 1 | 2021 | 73 | 0.050 |
Why?
| HLA-A Antigens | 1 | 2021 | 49 | 0.050 |
Why?
| Pharmacogenomic Variants | 1 | 2021 | 33 | 0.050 |
Why?
| Mexico | 1 | 2021 | 162 | 0.050 |
Why?
| Uterine Hemorrhage | 1 | 2021 | 34 | 0.050 |
Why?
| Drug Implants | 1 | 2021 | 70 | 0.050 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2023 | 498 | 0.050 |
Why?
| Ultrasonography | 1 | 2024 | 633 | 0.040 |
Why?
| Aged | 3 | 2023 | 19068 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2024 | 1691 | 0.040 |
Why?
| Altitude | 1 | 2023 | 432 | 0.040 |
Why?
| Alleles | 1 | 2022 | 789 | 0.040 |
Why?
| Oxygen | 1 | 2023 | 854 | 0.040 |
Why?
| Phylogeography | 1 | 2019 | 44 | 0.040 |
Why?
| Fetal Growth Retardation | 1 | 2023 | 467 | 0.040 |
Why?
| Genome Size | 1 | 2018 | 10 | 0.040 |
Why?
| Neoplasm Recurrence, Local | 1 | 2024 | 858 | 0.040 |
Why?
| Gene Expression | 1 | 2023 | 1421 | 0.040 |
Why?
| Feasibility Studies | 1 | 2021 | 740 | 0.040 |
Why?
| Hominidae | 1 | 2019 | 79 | 0.040 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2019 | 129 | 0.040 |
Why?
| Weight Gain | 1 | 2021 | 453 | 0.040 |
Why?
| Birds | 1 | 2018 | 76 | 0.040 |
Why?
| DNA Transposable Elements | 1 | 2018 | 101 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2019 | 502 | 0.040 |
Why?
| Hypoxia | 1 | 2023 | 957 | 0.040 |
Why?
| Self Report | 1 | 2021 | 696 | 0.040 |
Why?
| Young Adult | 2 | 2022 | 10465 | 0.030 |
Why?
| Mammals | 1 | 2018 | 244 | 0.030 |
Why?
| Protein Conformation | 1 | 2019 | 805 | 0.030 |
Why?
| Indians, North American | 1 | 2021 | 570 | 0.030 |
Why?
| Biological Evolution | 1 | 2019 | 416 | 0.030 |
Why?
| Incidence | 1 | 2021 | 2312 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 2019 | 1982 | 0.030 |
Why?
| Genome-Wide Association Study | 1 | 2021 | 1177 | 0.030 |
Why?
| Pandemics | 1 | 2022 | 1317 | 0.030 |
Why?
| Age Factors | 1 | 2021 | 2894 | 0.030 |
Why?
| Models, Molecular | 1 | 2019 | 1369 | 0.030 |
Why?
| Protein Binding | 1 | 2019 | 1889 | 0.030 |
Why?
| Prognosis | 1 | 2021 | 3327 | 0.030 |
Why?
| Genetic Predisposition to Disease | 1 | 2021 | 2085 | 0.030 |
Why?
| Risk Assessment | 1 | 2021 | 2968 | 0.020 |
Why?
| Biomarkers | 1 | 2021 | 3408 | 0.020 |
Why?
| Time Factors | 1 | 2021 | 6115 | 0.020 |
Why?
| Adult | 2 | 2021 | 30542 | 0.020 |
Why?
| Risk Factors | 1 | 2023 | 8631 | 0.020 |
Why?
| United States | 1 | 2021 | 12179 | 0.020 |
Why?
| Adolescent | 1 | 2021 | 17837 | 0.010 |
Why?
| Middle Aged | 1 | 2021 | 26732 | 0.010 |
Why?
|
|
Shortt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|